等待開盤 09-30 09:30:00 美东时间
-7.380
-2.32%
今日重点评级关注:HC Wainwright & Co.:维持GoldMining"买入"评级,目标价从3.25美元升至3.75美元;摩根士丹利:维持Crinetics Pharmaceuticals"超配"评级,目标价从65美元升至77美元
今天 14:16
6 analysts have shared their evaluations of Insulet (NASDAQ: PODD) during the recent three months, expressing a mix of bullish and bearish perspectives.
09-29 20:02
Canaccord Genuity analyst William Plovanic maintains Insulet (NASDAQ: PODD) with a Buy and raises the price target from $353 to $399.
09-29 19:55
Small-cap and blue-chip stocks advanced in Wednesday morning trading on Wall Street, while technology names lagged and the S&P 500 hovered near record levels as investors braced for the Federal Reserve's interest rate decision.
09-18 00:44
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts jus...
09-16 21:30
Insulet (NASDAQ:PODD) has named seasoned financial executive Flavia Pease as its new CFO, effective September 30, 2025. Pease will succeed Ana Maria Chadwick, who will stay on as senior advisor to hel...
09-16 19:11
PodcastOne announced its updated FY2026 guidance with expected Adjusted EBITDA of $4.5-6M and revenue of $55-60M. LiveOne has acquired an additional 347,000 shares of PodcastOne's common stock, bringing its total holdings to ~2.1 million shares.
09-12 12:00
Insulet shares are trading lower. Senior Vice President of Global Operations, P...
09-10 23:13
Throughout the last three months, 6 analysts have evaluated Insulet (NASDAQ:POD...
09-09 04:01
Oppenheimer analyst Steven Lichtman maintains Insulet (NASDAQ:PODD) with a Outperform and raises the price target from $324 to $365.
09-08 22:37